ISSN: 0973-7510
E-ISSN: 2581-690X
, R. Bharathi1, R. Bindu Madhavi1, Arvind Natarajan1 , H.S. Brindha2, S.M. Azeem Mohiyuddin2, R. Kalyani3, Anil Kumar Sakalecha4, Bukke Ravindra Naik4 and K.N. Shashidhar5Acute Invasive Fungal Rhinosinusitis (AIFR) is a serious condition with aggressive course and high mortality rates. There is an upsurge in the incidence of invasive fungal rhinosinusitis in post COVID-19 patients. We have come across 20 AIFR cases in post COVID-19 patients. On retrospective exploration of the patient’s records, we found that 30% patients had received steroids and 90% had diabetes. All the patients were managed by administration of IV amphotericin B and local debridement of infected tissues. The mortality rate was as low as 15 %. We conclude that combined approach of Antifungal therapy with debridement of infected tissues improves the prognosis and survival of AIFR patients.
COVID-19, Fungal Sinusitis, Aspergillus, Mucor, Fungal Culture
© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.